Malaria medicine being administered to 1,100 COVID19 patients in NY: Trump

March 30, 2020 12:32

Malaria medicine 'Hydroxychloroquine' is being administered to 1,100 coronavirus patients in New York, President Donald Trump has said, exuding confidence that the drug, touted as a "game-changer" by him, might give some incredible results in the fight against the disease that has infected over 140,000 people in the country.

An inexpensive drug widely used since 1955 to treat malaria, Hydroxychloroquine is considered to have relatively harmless side effects. It is being tested out on the COVID-19 patients in New York on an experimental basis, hoping that this will give a solution in the treatment against the novel coronavirus.

"Hydroxychloroquine is being administered to 1,100 patients, people in New York along with the Z-pack, which is azithromycin, and it is very early yet. It started two days ago, but we will see what happens,' Trump told reporters at a White House news conference. Last week, Trump said that the drug could be a "gift from God." -- PTI

« Back to LIVE

TOP STORIES

Rahul to contest LS polls from Rae Bareli, his loyalist from Amethi

Kishori Lal Sharma, a close aide of the Gandhi family, has been fielded from the Amethi Lok Sabha seat, the party said in a statement.

Cummins and Bhuvi showed their class: Head

Sunrisers Hyderabad opener Travis Head admitted that the hosts "didn't expect" to end the night at Rajiv Gandhi International Stadium with a victory against Rajasthan Royals in the ongoing Indian Premier League.

Why Rahul Gandhi opted for Rae Bareli instead of Amethi

Amid criticism that the Congress had given a walkout to Irani in Amethi, sources said, the party in its wisdom believed that Rae Bareli's historical, emotional and electoral importance for the Gandhi family was higher than that of Amethi.

Sanju Era Begins!

Scenes from the RR-SRH game...

'India Offers Once In A Lifetime Opportunity To Create Wealth'

'We see mid-and small-caps as a real pot of gold.' 'From a 10-15 years perspective, mid-and small-cap are likely to outperform the larger index, as they have done in the past.'